Financials

  • Market Capitalization 3.83 B
  • Employee 601
  • Founded 2015
  • CEO -
  • Website www.arcusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00DQD26W3
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.93
ratio cours/chiffre d'affaires
30.46

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1523
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
34.48 USD+1.98%-4.91%+69.94%+246.53%3.84 B USD
1525
IOVA
Iovance Biotherapeutics, Inc. - Common Stock
8.46 USD+2.17%-0.12%+106.34%+288.07%3.83 B USD
1555
DNLI
Denali Therapeutics Inc. - Common Stock
23.16 USD-0.47%-5.74%+1.36%+43.23%3.70 B USD
1560
TNGX
Tango Therapeutics, Inc. - Common Stock
21.80 USD-2.46%-13.97%-18.75%+229.31%3.68 B USD

Nouvelles